IN8bio inc.Target prices between 3.50 $ - 4.00 $
Explosive Level we are in now , any moment could be exploded up fast
The Resistance level now is 0.2400 $ will be reach very soon
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−8.7208 EUR
−29.40 M EUR
0.00 EUR
3.88 M
About IN8bio, Inc.
Sector
Industry
CEO
William T. Ho
Website
Headquarters
New York
Founded
2016
ISIN
US45674E2081
IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S. Lamb and William T. Ho on February 8, 2016 and is headquartered in New York, NY.
Related stocks
$INAB Will It Become A Notable Biotech Stock?One of the reasons why cancer is so hard to treat is that the body has a hard time identifying cancerous cells. IN8bio, Inc. (Nasdaq: INAB) seeks to solve this issue through gamma-delta T cell therapy, which assists the body in identifying cancerous cells and targeting them with a thorough immune re
IN8bio's down turn should continue before a a pullbackIN8bio ssould continue it's downward spiraling channel play. Traded it a few times already.
Expect it to go down to the $5.20 - $5 for a reasonable enrty into a long position (back up to the top channel).
There is no social media buzz, the company seems relatively unknown.
Volume here is tiny, po
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently Asked Questions
The current price of A4197Y is 1.8800 EUR — it has decreased by −6.74% in the past 24 hours. Watch IN8bio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSX exchange IN8bio, Inc. stocks are traded under the ticker A4197Y.
A4197Y stock has fallen by −8.16% compared to the previous week, the month change is a −1.64% fall, over the last year IN8bio, Inc. has showed a −5.81% decrease.
We've gathered analysts' opinions on IN8bio, Inc. future price: according to them, A4197Y price has a max estimate of 51.27 EUR and a min estimate of 2.56 EUR. Watch A4197Y chart and read a more detailed IN8bio, Inc. stock forecast: see what analysts think of IN8bio, Inc. and suggest that you do with its stocks.
A4197Y reached its all-time high on Jul 10, 2025 with the price of 2.2250 EUR, and its all-time low was 1.7260 EUR and was reached on Aug 4, 2025. View more price dynamics on A4197Y chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
A4197Y stock is 4.26% volatile and has beta coefficient of 1.83. Track IN8bio, Inc. stock price on the chart and check out the list of the most volatile stocks — is IN8bio, Inc. there?
Today IN8bio, Inc. has the market capitalization of 8.39 M, it has decreased by −1.88% over the last week.
Yes, you can track IN8bio, Inc. financials in yearly and quarterly reports right on TradingView.
IN8bio, Inc. is going to release the next earnings report on Nov 6, 2025. Keep track of upcoming events with our Earnings Calendar.
A4197Y earnings for the last quarter are −1.05 EUR per share, whereas the estimation was −1.46 EUR resulting in a 28.12% surprise. The estimated earnings for the next quarter are −1.05 EUR per share. See more details about IN8bio, Inc. earnings.
IN8bio, Inc. revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
A4197Y net income for the last quarter is −4.32 M EUR, while the quarter before that showed −5.13 M EUR of net income which accounts for 15.71% change. Track more IN8bio, Inc. financial stats to get the full picture.
No, A4197Y doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 8, 2025, the company has 18 employees. See our rating of the largest employees — is IN8bio, Inc. on this list?
Like other stocks, A4197Y shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IN8bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.